Stockreport

Here's Why We're Not Too Worried About Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Situation [Yahoo! Finance]

Jasper Therapeutics, Inc. - Class A  (JSPR) 
PDF lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But while history lauds those rare successes, thos [Read more]